Norway's Pharmaceutical Revolution PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Norway's Pharmaceutical Revolution PDF full book. Access full book title Norway's Pharmaceutical Revolution by Knut Sogner. Download full books in PDF and EPUB format.
Author: Knut Sogner
Publisher: Oxford University Press
ISBN: 0192695592
Category : Business & Economics
Languages : en
Pages : 273
Get Book Here
Book Description
The pharmaceutical revolution that gathered pace in the 1930s delivered a plethora of almost magical new drugs such as penicillin, streptomycin, cortisone, and the birth control pill. This revolution grew from academic-business relationships in five countries: USA, Germany, Great Britain, Switzerland, and France. Many other countries tried and failed to replicate this success, yet a handful of Scandinavia companies made important breakthroughs in a narrow band of specialities. This is the story of how one Norwegian company— Nyegaard & Co. —achieved international success from the 1970s onwards with a breakthrough product facilitating X-ray pictures of the soft tissues of the body. The company succeeded by harnessing research skills and creating scientific and business alliances abroad, building its own momentum step by step: the corporation as entrepreneur. It thereby broke with the conventional way a national medical ecosystem facilitated the crucial scientific progress. This is a story both of personal initiatives and great organizational transformations in several stages. In the 1950s, Nyegaard & Co. was a small hierarchical home market-oriented generics company. By the end of the 1990s, it had developed into a fairly large and multinational hierarchical company, preoccupied as much with shareholder value as scientific progress. It has also become a company that no longer had the same ability to innovate as before and therefore became merged into another one.
Author: Knut Sogner
Publisher: Oxford University Press
ISBN: 0192695592
Category : Business & Economics
Languages : en
Pages : 273
Get Book Here
Book Description
The pharmaceutical revolution that gathered pace in the 1930s delivered a plethora of almost magical new drugs such as penicillin, streptomycin, cortisone, and the birth control pill. This revolution grew from academic-business relationships in five countries: USA, Germany, Great Britain, Switzerland, and France. Many other countries tried and failed to replicate this success, yet a handful of Scandinavia companies made important breakthroughs in a narrow band of specialities. This is the story of how one Norwegian company— Nyegaard & Co. —achieved international success from the 1970s onwards with a breakthrough product facilitating X-ray pictures of the soft tissues of the body. The company succeeded by harnessing research skills and creating scientific and business alliances abroad, building its own momentum step by step: the corporation as entrepreneur. It thereby broke with the conventional way a national medical ecosystem facilitated the crucial scientific progress. This is a story both of personal initiatives and great organizational transformations in several stages. In the 1950s, Nyegaard & Co. was a small hierarchical home market-oriented generics company. By the end of the 1990s, it had developed into a fairly large and multinational hierarchical company, preoccupied as much with shareholder value as scientific progress. It has also become a company that no longer had the same ability to innovate as before and therefore became merged into another one.
Author: Bjørn T. Asheim
Publisher: Edward Elgar Publishing
ISBN: 1035313170
Category : Education
Languages : en
Pages : 367
Get Book Here
Book Description
This is an open access title available under the terms of a CC BY-NC-ND 4.0 License. It is free to read, download and share on Elgaronline.com. Promoting more responsible action in relation to business sustainability, this book addresses the increasing discomfort among faculty members and wider society as to how business schools prepare students for the future. Reflective and inspiring, it seeks to motivate the necessary action which may be a small but crucial catalysts to solving challenges posed by increasing globalisation, migration, economic development, changing demographics, and cultural exchange.
Author: Knut Sogner
Publisher:
ISBN: 9780192695581
Category : Electronic books
Languages : en
Pages : 0
Get Book Here
Book Description
This is the story of how Norwegian company Nyegaard & Co. achieved international success in pharmaceuticals with a breakthrough product facilitating X-ray pictures of the soft tissues of the body. It is a story of both of personal initiatives and great organizational transformations: the corporation as entrepreneur.
Author: Ursula Sharma
Publisher: Psychology Press
ISBN: 9780415047944
Category : Health & Fitness
Languages : en
Pages : 250
Get Book Here
Book Description
Complementary Medicine Todayprovides an examination of current British medical practice and demonstrates the ways in which the social sciences can clarify some of the practical, political, and ethical issues raised by alternative health care.
Author: Robert Whitaker
Publisher: Hachette UK
ISBN: 1541646398
Category : Psychology
Languages : en
Pages : 384
Get Book Here
Book Description
An updated edition of the classic history of schizophrenia in America, which gives voice to generations of patients who suffered through "cures" that only deepened their suffering and impaired their hope of recovery Schizophrenics in the United States currently fare worse than patients in the world's poorest countries. In Mad in America, medical journalist Robert Whitaker argues that modern treatments for the severely mentally ill are just old medicine in new bottles, and that we as a society are deeply deluded about their efficacy. The widespread use of lobotomies in the 1920s and 1930s gave way in the 1950s to electroshock and a wave of new drugs. In what is perhaps Whitaker's most damning revelation, Mad in America examines how drug companies in the 1980s and 1990s skewed their studies to prove that new antipsychotic drugs were more effective than the old, while keeping patients in the dark about dangerous side effects. A haunting, deeply compassionate book -- updated with a new introduction and prologue bringing in the latest medical treatments and trends -- Mad in America raises important questions about our obligations to the mad, the meaning of "insanity," and what we value most about the human mind.
Author: Alfred D. Chandler Jr.
Publisher: Harvard University Press
ISBN: 0674029372
Category : Business & Economics
Languages : en
Pages : 379
Get Book Here
Book Description
The dean of business historians continues his masterful chronicle of the transforming revolutions of the twentieth century begun in Inventing the Electronic Century. Alfred Chandler argues that only with consistent attention to research and development and an emphasis on long-term corporate strategies could firms remain successful over time. He details these processes for nearly every major chemical and pharmaceutical firm, demonstrating why some companies forged ahead while others failed. By the end of World War II, the chemical and pharmaceutical industries were transformed by the commercializing of new learning, the petrochemical and the antibiotic revolutions. But by the 1970s, chemical science was no longer providing the new learning necessary to commercialize more products, although new directions flourished in the pharmaceutical industries. In the 1980s, major drug companies, including Eli Lilly, Merck, and Schering Plough, commercialized the first biotechnology products, and as the twenty-first century began, the infrastructure of this biotechnology revolution was comparable to that of the second industrial revolution just before World War I and the information revolution of the 1960s. Shaping the Industrial Century is a major contribution to our understanding of the most dynamic industries of the modern era.
Author: Lee A. Tavis
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 424
Get Book Here
Book Description
The book begins by analyzing the overall issue of multinational pharmaceutical corporate involvement in Third World locations. The contributors discuss the broad issue of conflict and collaboration between multinational corporations and activists, the role of pharmaceuticals in Third World health care, and the role of multinational corporations in that process.
Author: Nessa Carey
Publisher: Columbia University Press
ISBN: 0231530714
Category : Science
Languages : en
Pages : 353
Get Book Here
Book Description
Epigenetics can potentially revolutionize our understanding of the structure and behavior of biological life on Earth. It explains why mapping an organism's genetic code is not enough to determine how it develops or acts and shows how nurture combines with nature to engineer biological diversity. Surveying the twenty-year history of the field while also highlighting its latest findings and innovations, this volume provides a readily understandable introduction to the foundations of epigenetics. Nessa Carey, a leading epigenetics researcher, connects the field's arguments to such diverse phenomena as how ants and queen bees control their colonies; why tortoiseshell cats are always female; why some plants need cold weather before they can flower; and how our bodies age and develop disease. Reaching beyond biology, epigenetics now informs work on drug addiction, the long-term effects of famine, and the physical and psychological consequences of childhood trauma. Carey concludes with a discussion of the future directions for this research and its ability to improve human health and well-being.
Author: Klaus Schwab
Publisher: Crown Currency
ISBN: 1524758876
Category : Business & Economics
Languages : en
Pages : 194
Get Book Here
Book Description
World-renowned economist Klaus Schwab, Founder and Executive Chairman of the World Economic Forum, explains that we have an opportunity to shape the fourth industrial revolution, which will fundamentally alter how we live and work. Schwab argues that this revolution is different in scale, scope and complexity from any that have come before. Characterized by a range of new technologies that are fusing the physical, digital and biological worlds, the developments are affecting all disciplines, economies, industries and governments, and even challenging ideas about what it means to be human. Artificial intelligence is already all around us, from supercomputers, drones and virtual assistants to 3D printing, DNA sequencing, smart thermostats, wearable sensors and microchips smaller than a grain of sand. But this is just the beginning: nanomaterials 200 times stronger than steel and a million times thinner than a strand of hair and the first transplant of a 3D printed liver are already in development. Imagine “smart factories” in which global systems of manufacturing are coordinated virtually, or implantable mobile phones made of biosynthetic materials. The fourth industrial revolution, says Schwab, is more significant, and its ramifications more profound, than in any prior period of human history. He outlines the key technologies driving this revolution and discusses the major impacts expected on government, business, civil society and individuals. Schwab also offers bold ideas on how to harness these changes and shape a better future—one in which technology empowers people rather than replaces them; progress serves society rather than disrupts it; and in which innovators respect moral and ethical boundaries rather than cross them. We all have the opportunity to contribute to developing new frameworks that advance progress.
Author: Brent R. Stockwell
Publisher: Columbia University Press
ISBN: 0231525524
Category : Medical
Languages : en
Pages : 289
Get Book Here
Book Description
After more than fifty years of blockbuster drug development, skeptics are beginning to fear we are reaching the end of drug discovery to combat major diseases. In this engaging book, Brent R. Stockwell, a leading researcher in the exciting new science of chemical biology, describes this dilemma and the powerful techniques that may bring drug research into the twenty-first century. Filled with absorbing stories of breakthroughs, this book begins with the scientific achievements of the twentieth century that led to today's drug innovations. We learn how the invention of mustard gas in World War I led to early anti-cancer agents and how the efforts to decode the human genome might lead to new approaches in drug design. Stockwell then turns to the seemingly incurable diseases we face today, such as Alzheimer's, many cancers, and others with no truly effective medicines, and details the cellular and molecular barriers thwarting scientists equipped with only the tools of traditional pharmaceutical research. Scientists such as Stockwell are now developing methods to combat these complexities technologies for constructing and testing millions of drug candidates, sophisticated computational modeling, and entirely new classes of drug molecules all with an eye toward solving the most profound mysteries of living systems and finding cures for intractable diseases. If successful, these methods will unlock a vast terrain of untapped drug targets that could lead to a bounty of breakthrough medicines. Offering a rare, behind-the-scenes look at this cutting-edge research, The Quest for the Cure tells a thrilling story of science, persistence, and the quest to develop a new generation of cures.
